Title: Garner F, et al. RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models. Anticancer Drugs. 2015 Oct;26(9):948-56.
722533-56-4
1334177-84-2 | t-Butyl 3-Hydroxy(peg8)propionate | AA009IQF | MFCD11041105
143059-69-2 | cefaclor iMpurity C | AA009JJ0
13645-74-4 | 4,5-Dibromo-2-methylpyridazin-3(2H)-one | AA009K1P | MFCD00135076
1082041-27-7 | 2-Chloro-4-nitro-5-bromopyridine | AA009LU2 | MFCD11007830
107492-79-5 | Ethanone, 1-(4-pyridinyl)-, oxime, (1Z)- (9CI) | AA009NOX | MFCD00180593
107726-24-9 | 6-Ethyl-1H-benzimidazol-2-ylamine | AA009P6A | MFCD04967056
11076-29-2 | Acetyl-Pepstatin | AA009RKK | MFCD00214071
114650-82-7 | 1H-Pyrrole-1-carboxylic acid, 2,5-dihydro-2,5-dioxo-, 1,1-diMethylethyl ester | AA009UM5 | MFCD09972233
1337880-79-1 | 3-Aminoisoquinoline-6-carboxylic acid | AA009VTP | MFCD22380192
133261-08-2 | Ethyl 3-isopropyl-1-methyl-1h-pyrazole-5-carboxylate | AA009W7C | MFCD17193478